ES550008A0 - Un procedimiento para la preparacion de una proteina hibridafibrinoliticamente activa - Google Patents

Un procedimiento para la preparacion de una proteina hibridafibrinoliticamente activa

Info

Publication number
ES550008A0
ES550008A0 ES550008A ES550008A ES550008A0 ES 550008 A0 ES550008 A0 ES 550008A0 ES 550008 A ES550008 A ES 550008A ES 550008 A ES550008 A ES 550008A ES 550008 A0 ES550008 A0 ES 550008A0
Authority
ES
Spain
Prior art keywords
hybrid
procedure
preparation
active protein
fibrinolytically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES550008A
Other languages
English (en)
Other versions
ES8702494A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES8702494A1 publication Critical patent/ES8702494A1/es
Publication of ES550008A0 publication Critical patent/ES550008A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
ES550008A 1983-12-24 1985-12-16 Un procedimiento para la preparacion de una proteina hibridafibrinoliticamente activa Expired ES8702494A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838334498A GB8334498D0 (en) 1983-12-24 1983-12-24 Compounds

Publications (2)

Publication Number Publication Date
ES8702494A1 ES8702494A1 (es) 1987-01-01
ES550008A0 true ES550008A0 (es) 1987-01-01

Family

ID=10553870

Family Applications (2)

Application Number Title Priority Date Filing Date
ES538999A Expired ES8606493A1 (es) 1983-12-24 1984-12-21 Un procedimiento para la preparacion de una proteina hibrida fibrinoliticamente activa
ES550008A Expired ES8702494A1 (es) 1983-12-24 1985-12-16 Un procedimiento para la preparacion de una proteina hibridafibrinoliticamente activa

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES538999A Expired ES8606493A1 (es) 1983-12-24 1984-12-21 Un procedimiento para la preparacion de una proteina hibrida fibrinoliticamente activa

Country Status (11)

Country Link
US (3) US4752581A (es)
EP (1) EP0155387B1 (es)
JP (1) JPS60252422A (es)
AU (1) AU580023B2 (es)
DE (1) DE3479632D1 (es)
ES (2) ES8606493A1 (es)
GB (1) GB8334498D0 (es)
GR (1) GR82557B (es)
IE (1) IE57946B1 (es)
NZ (1) NZ210697A (es)
ZA (1) ZA849924B (es)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334498D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Compounds
US4880776A (en) * 1983-12-24 1989-11-14 Beecham Group P.L.C. Plasmin A-chain urokinase B-chain hybrid protein
GB8609948D0 (en) * 1986-04-23 1986-05-29 Beecham Group Plc Compounds
US5234686A (en) * 1985-04-03 1993-08-10 Beecham Group P.L.C. Human tissue plasminogen activator consisting essentially of t-PA residues to 160 to 527, pharmaceutical compositions and methods of treatment
US4916071A (en) * 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator
US5045315A (en) * 1985-08-14 1991-09-03 American Home Products Corporation Process for treating thrombosis by administering poly-kringle plasminogen activator
US4997766A (en) * 1986-07-11 1991-03-05 American Home Products Corporation Poly-kringle plasminogen activator
DE3781420T2 (de) * 1986-01-31 1993-02-25 Sagami Chem Res Hybrides plasminogenaktivatoraehnliches polypeptid.
US5204255A (en) * 1986-01-31 1993-04-20 Sagami Chemical Research Center Hybrid tissue plasminogen activator/urokinase polypeptides
US4828988A (en) * 1986-05-15 1989-05-09 Smith Kline - Rit Hybrid polypeptides comprising somatocrinine and alpha1 -antitrypsin, method for their production from bacterial clones and use thereof for the production of somatocrinine
US6150328A (en) * 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
FI100106B (fi) * 1986-12-05 1997-09-30 Novartis Ag Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi
US5242819A (en) * 1986-12-05 1993-09-07 Ciba-Geigy Corporation DNA molecules encoding hybrid proteins of tissue plasminogen activator and urokinase
US5580559A (en) * 1986-12-05 1996-12-03 Ciba-Geigy Corporation Hybrid plasminogen activator
ZA879286B (en) * 1986-12-16 1988-10-26 Smith Kline Rit New plasminogen activators
WO1988005081A2 (en) * 1986-12-30 1988-07-14 Cetus Corporation Novel plasminogen activator
NL8700013A (nl) * 1987-01-06 1988-08-01 Leuven Res & Dev Vzw Hybride plasminogeenactivatoren met verbeterde trombolytische eigenschappen en geneesmiddelen die deze plasminogeenactivatoren bevatten.
GB8705377D0 (en) * 1987-03-07 1987-04-08 Beecham Group Plc Compounds
GB8707369D0 (en) * 1987-03-27 1987-04-29 Beecham Group Plc Enzyme derivatives
NL8701021A (nl) * 1987-04-29 1988-11-16 Stichting Centraal Lab Humane t-pa(u-pa) substitutie-mutant eiwitten, daarvoor coderend recombinant dna, getransfecteerde gastheercellen, bereiding van de mutant eiwitten, en farmaceutische preparaten.
GB8711957D0 (en) * 1987-05-20 1987-06-24 Beecham Group Plc Compounds
ZA884012B (en) * 1987-06-04 1989-02-22 Zymogenetics Inc Tissue plasminogen activator analogs having modified growth factor domains
US5149533A (en) * 1987-06-04 1992-09-22 Zymogenetics, Inc. Modified t-PA with kringle-/replaced by another kringle
GB8715302D0 (en) * 1987-06-30 1987-08-05 Ordidge R J Nmr spectroscopy
IL86909A0 (en) * 1987-07-01 1988-11-30 Beecham Group Plc Hybrid plasminogen activator,dna coding therefor,derivatives of said plasminogen activator and pharmaceutical compositions containing said plasminogen activator or said derivatives
US5302390A (en) * 1987-07-01 1994-04-12 Beecham Group Plc Hybrid proteins of human plasminogen and human t-PA, pharmaceutical compositions and methods of treatment
AU2081788A (en) * 1987-07-06 1989-01-30 Genetics Institute Inc. Novel thrombolytic proteins
JP2708749B2 (ja) * 1987-08-10 1998-02-04 エーザイ株式会社 修飾型ｔＰＡ含有注射用組成物
WO1990001332A1 (en) * 1988-08-10 1990-02-22 Cetus Corporation Plasminogen activator-heparin conjugates
US4892826A (en) * 1988-10-11 1990-01-09 Abbott Laboratories Process for the preparation of urokinase derivatives
US5198346A (en) * 1989-01-06 1993-03-30 Protein Engineering Corp. Generation and selection of novel DNA-binding proteins and polypeptides
US5096815A (en) * 1989-01-06 1992-03-17 Protein Engineering Corporation Generation and selection of novel dna-binding proteins and polypeptides
AU6470590A (en) 1989-10-23 1991-04-26 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
US5227297A (en) * 1990-04-17 1993-07-13 Smithkline Beecham Corporation Affinity purification ligands
US5141862A (en) * 1990-04-17 1992-08-25 Smithkline Beecham Corporation Method of purifying tpa or plasminogen activator using a tripeptide of the formula: -X-Y-argininal wherein X and Y are selected from the group consisting of pro,phe,trp and tyr
GB9013345D0 (en) * 1990-06-14 1990-08-08 Beecham Group Plc Novel compounds
US5632986A (en) * 1991-05-09 1997-05-27 The University Of Washington Phospholipid-targeted thrombolytic agents
ATE238417T1 (de) * 1991-11-04 2003-05-15 Inst Genetics Llc Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
US20080070842A1 (en) * 1991-11-04 2008-03-20 David Israel Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
WO1993014199A1 (en) * 1992-01-13 1993-07-22 Abbott Laboratories A pump-1 catalyzed method of making low molecular weight urokinase-type plasminogen activator
US6291206B1 (en) * 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
AU689184B2 (en) * 1993-12-07 1998-03-26 Genetics Institute, Llc BMP-12, BMP-13 and tendon-inducing compositions thereof
GB9614871D0 (en) 1996-07-15 1996-09-04 Smithkline Beecham Plc Compounds
US6727224B1 (en) * 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
AU774427B2 (en) 1999-10-15 2004-06-24 Fidia Advanced Biopolymers S.R.L. Formulations of hyaluronic acid for delivery of osteogenic proteins
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6355243B1 (en) 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US6964764B2 (en) * 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6969515B2 (en) 1999-11-13 2005-11-29 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US20030082233A1 (en) * 2000-12-01 2003-05-01 Lyons Karen M. Method and composition for modulating bone growth
ATE393573T1 (de) * 2001-06-01 2008-05-15 Wyeth Corp Zusammensetzungen für die systemische verabreichung von sequenzen, die für knochenmorphogenese-proteinen kodieren
TWI267378B (en) * 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
TW200638946A (en) * 2002-05-17 2006-11-16 Wyeth Corp Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
RU2363478C2 (ru) * 2003-09-12 2009-08-10 Вайет Инъецируемые стержни из фосфата кальция для доставки остеогенных белков
US8124588B2 (en) * 2003-12-18 2012-02-28 Justus Liebig Universität Giessen Chimeric plasminogen activators and their pharmaceutical use
JP2011522538A (ja) * 2008-06-04 2011-08-04 タレクリス・バイオセラピユーテイクス・インコーポレーテツド プラスミン製造のための組成物、方法およびキット
PT2403865E (pt) 2009-03-03 2015-11-18 Grifols Therapeutics Inc Métodos de preparação de plasminogénio

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082612A (en) * 1976-09-24 1978-04-04 Michael Reese Research Foundation Plasminogen activator complex
NZ191320A (en) * 1978-09-07 1982-09-14 Beecham Group Ltd In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions
AU546758B2 (en) * 1980-03-03 1985-09-19 Ryan, A.T. Feeding granular material into a gas stream
ZA831399B (en) * 1982-03-05 1984-02-29 Health Lab Service Board New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them
DE3361610D1 (en) * 1982-04-07 1986-02-06 Beecham Group Plc Enzyme derivatives, process for preparing them and pharmaceutical compositions containing them
AU3745285A (en) * 1983-11-29 1985-06-13 Igen, Inc. Method of catalyzing chemical reactions
JPS60136520A (ja) * 1983-12-23 1985-07-20 Otsuka Pharmaceut Co Ltd フイブリン吸着性ウロキナ−ゼ複合体
GB8334498D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Compounds
GB8334499D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Derivatives
GB8508717D0 (en) * 1985-04-03 1985-05-09 Beecham Group Plc Composition
US4916071A (en) * 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator

Also Published As

Publication number Publication date
NZ210697A (en) 1989-06-28
JPS60252422A (ja) 1985-12-13
EP0155387A2 (en) 1985-09-25
EP0155387A3 (en) 1986-12-30
ES8702494A1 (es) 1987-01-01
AU3707184A (en) 1985-07-04
GR82557B (en) 1985-04-23
ZA849924B (en) 1986-04-30
IE57946B1 (en) 1993-05-19
EP0155387B1 (en) 1989-09-06
ES8606493A1 (es) 1986-04-01
US4752581A (en) 1988-06-21
ES538999A0 (es) 1986-04-01
IE843332L (en) 1985-06-24
US4992274A (en) 1991-02-12
DE3479632D1 (en) 1989-10-12
US4908204A (en) 1990-03-13
AU580023B2 (en) 1988-12-22
GB8334498D0 (en) 1984-02-01

Similar Documents

Publication Publication Date Title
ES538999A0 (es) Un procedimiento para la preparacion de una proteina hibrida fibrinoliticamente activa
ES557677A0 (es) Un procedimiento para preparar una proteina hibrida fibrinoliticamente activa.
ES539432A0 (es) Un procedimiento para preparar un conjugado de proteina fibrinoliticamente activa
ES536590A0 (es) Un procedimiento para la preparacion de n-(heterociclilbiciclo)-4-piperidinaminas.
ES533285A0 (es) Un procedimiento para la preparacion de nuevos oligopeptidos.
ES529171A0 (es) Un procedimiento para la preparacion de una cefalosporina.
ES503188A0 (es) Un procedimiento para la preparacion de una 1-benzoil-urea 3-sustituida
ES511079A0 (es) Un procedimiento para la preparacion de una n-(2-pirimidinil) piperazinilalquilazaespiroalcanodiona.
ES528497A0 (es) Procedimiento para la preparacion de una proteina hipocolesterolemicamente activa
ES531897A0 (es) Procedimiento para obtener una proteina heterologa para levaduras
ES536728A0 (es) Un procedimiento para la preparacion de nuevos antibioticos de cefalosporina.
MX7572E (es) Procedimiento para preparar proteina unicelular
ES530081A0 (es) Un procedimiento para la preparacion de una macrolida
MX156049A (es) Un procedimiento para la preparacion de una n - piperazinilalcanolanilida
MX7655E (es) Procedimiento para preparar substancias proteinicas antitumorales
ES535727A0 (es) Un procedimiento para la preparacion de nuevos peptidos.
MX5601E (es) Procedimiento para la separacion de una mezcla de fenil-glicina-amida opticamente activa y una fenil glicina opticamente activa
ES544640A0 (es) Un procedimiento para la preparacion de una cefalosporina
ES534066A0 (es) Un procedimiento para la preparacion de antibioticos de b-lactama.
ES528985A0 (es) Un procedimiento para la preparacion de una b- lactama
ES553705A0 (es) Un procedimiento para la preparacion de una alcanoilanilida
ES534737A0 (es) Procedimiento para la preparacion de fenilalanina opticamente activa
ES522278A0 (es) Un procedimiento para preparacion de una quinalozina.
ES530219A0 (es) Un procedimiento para la preparacion de una macrolida
ES534480A0 (es) Procedimiento para la fabricacion de una pieza forjada

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519